S Rijal

Summary

Publications

  1. pmc The alcohol use disorders identification test (AUDIT): validation of a Nepali version for the detection of alcohol use disorders and hazardous drinking in medical settings
    Bickram Pradhan
    Department of Internal Medicine, B, P Koirala Institute of Health Sciences, Dharan, Nepal
    Subst Abuse Treat Prev Policy 7:42. 2012
  2. pmc Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs
    M Mamun Huda
    Centre for Communicable Diseases, ICDDR, B, Dhaka, Bangladesh
    BMC Public Health 12:1001. 2012
  3. pmc Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests
    Sören L Becker
    Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
    BMC Infect Dis 13:37. 2013
  4. pmc An outbreak investigation of visceral leishmaniasis among residents of Dharan town, eastern Nepal, evidence for urban transmission of Leishmania donovani
    Surendra Uranw
    B P Koirala Institute of Health Sciences, Ghopa, Dharan, Nepal
    BMC Infect Dis 13:21. 2013
  5. doi request reprint Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance
    Suman Rijal
    B P Koirala Institute of Health Sciences, Dharan, Nepal
    Clin Infect Dis 56:1530-8. 2013
  6. ncbi request reprint Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal
    S Rijal
    B P Koirala Institute of Health Sciences, Dharan, Nepal
    Trop Med Int Health 9:724-9. 2004
  7. ncbi request reprint The economic burden of visceral leishmaniasis for households in Nepal
    S Rijal
    Department of Medicine, B P Koirala Institute of Health Sciences, Dharan, Nepal
    Trans R Soc Trop Med Hyg 100:838-41. 2006
  8. doi request reprint Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal
    Suman Rijal
    BP Koirala Institute of Health Sciences, Ghopa, Dharan, Nepal
    Trop Med Int Health 15:21-8. 2010
  9. doi request reprint Clinical risk factors for therapeutic failure in kala-azar patients treated with pentavalent antimonials in Nepal
    S Rijal
    Department of Internal Medicine, B P Koirala Institute of Health Sciences, Dharan 056700, Nepal
    Trans R Soc Trop Med Hyg 104:225-9. 2010
  10. ncbi request reprint Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline
    S Rijal
    B P Koirala Institute of Health Sciences, Dharan, Nepal
    Trans R Soc Trop Med Hyg 97:350-4. 2003

Collaborators

Detail Information

Publications23

  1. pmc The alcohol use disorders identification test (AUDIT): validation of a Nepali version for the detection of alcohol use disorders and hazardous drinking in medical settings
    Bickram Pradhan
    Department of Internal Medicine, B, P Koirala Institute of Health Sciences, Dharan, Nepal
    Subst Abuse Treat Prev Policy 7:42. 2012
    ..This study aims to validate a Nepali version of AUDIT among patients attending a university hospital and assess the prevalence of alcohol use disorders along the full spectrum of alcohol misuse...
  2. pmc Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs
    M Mamun Huda
    Centre for Communicable Diseases, ICDDR, B, Dhaka, Bangladesh
    BMC Public Health 12:1001. 2012
    ..This paper evaluates the performance and feasibility of adapting ACD strategies into national programs for VL elimination in Bangladesh, India and Nepal...
  3. pmc Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests
    Sören L Becker
    Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
    BMC Infect Dis 13:37. 2013
    ..We provide an overview of pathogens causing digestive disorders in the tropics and evaluate available reference tests...
  4. pmc An outbreak investigation of visceral leishmaniasis among residents of Dharan town, eastern Nepal, evidence for urban transmission of Leishmania donovani
    Surendra Uranw
    B P Koirala Institute of Health Sciences, Ghopa, Dharan, Nepal
    BMC Infect Dis 13:21. 2013
    ..Since 1997 VL cases have also been reported among residents of the city of Dharan. Our main research objective was to find out whether there had been local transmission of VL inside the city...
  5. doi request reprint Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance
    Suman Rijal
    B P Koirala Institute of Health Sciences, Dharan, Nepal
    Clin Infect Dis 56:1530-8. 2013
    ..Given the paucity of anti-VL drugs and the looming threat of resistance, there is an obvious need for close monitoring of clinical efficacy of MIL...
  6. ncbi request reprint Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal
    S Rijal
    B P Koirala Institute of Health Sciences, Dharan, Nepal
    Trop Med Int Health 9:724-9. 2004
    ....
  7. ncbi request reprint The economic burden of visceral leishmaniasis for households in Nepal
    S Rijal
    Department of Medicine, B P Koirala Institute of Health Sciences, Dharan, Nepal
    Trans R Soc Trop Med Hyg 100:838-41. 2006
    ..Direct costs consisted of 53% of the total cost, with 75% of this cost incurred before the patients actually received any treatment for VL. This study demonstrates how VL can lead to catastrophic expenditure for affected households...
  8. doi request reprint Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal
    Suman Rijal
    BP Koirala Institute of Health Sciences, Ghopa, Dharan, Nepal
    Trop Med Int Health 15:21-8. 2010
    ..We report data on prevalence rates of Leishmania donovani infection in ten communities in East Nepal...
  9. doi request reprint Clinical risk factors for therapeutic failure in kala-azar patients treated with pentavalent antimonials in Nepal
    S Rijal
    Department of Internal Medicine, B P Koirala Institute of Health Sciences, Dharan 056700, Nepal
    Trans R Soc Trop Med Hyg 104:225-9. 2010
    ..1), interruption of treatment (OR=4.3) and ambulatory treatment (OR=10.2). Early diagnosis and supervised treatment is of paramount importance to prevent treatment failures within the control programme...
  10. ncbi request reprint Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline
    S Rijal
    B P Koirala Institute of Health Sciences, Dharan, Nepal
    Trans R Soc Trop Med Hyg 97:350-4. 2003
    ..These findings indicate that the spread of resistance to antimonials is already taking place in Nepal and that a policy to control further spread should be urgently implemented...
  11. doi request reprint Comparative study of kala-azar vector control measures in eastern Nepal
    M L Das
    Department of Microbiology, B P Koirala Institute of Health Sciences, Dharan, Nepal
    Acta Trop 113:162-6. 2010
    ..Hence, IRS was found most effective control measure to decrease vector density. LLINs were also found effective and can be considered as a promising alternative vector control tool in VL elimination initiative...
  12. ncbi request reprint Sodium stibogluconate cardiotoxicity and safety of generics
    S Rijal
    B P Koirala Institute of Health Sciences, Dharan, Nepal
    Trans R Soc Trop Med Hyg 97:597-8. 2003
    ..These data show that every batch of generic SSG should be subject to rigorous quality control prior to use...
  13. ncbi request reprint Lymphatic leishmaniasis--first case report from Nepal
    S K Sharma
    BP Koirala Institute of Health Sciences, Dharan, Nepal
    Southeast Asian J Trop Med Public Health 32:749-50. 2001
    ..The bone marrow aspiration was negative for Leishmania donovani body. This is the first case of lymphatic leishmaniasis reported from Nepal...
  14. ncbi request reprint Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine
    H Sangraula
    Department of Pharmacology, BP Koirala Institute of Health Sciences, Dharan, Nepal
    J Assoc Physicians India 51:686-90. 2003
    ..It is expected that in future we would have effective ways to prevent and treat all forms of leishmaniasis without discomforting the patient...
  15. doi request reprint Visceral leishmaniasis on the Indian sub-continent: a multi-centre study of the costs of three interventions for the control of the sandfly vector, Phlebotomus argentipes
    M Das
    B P Koirala Institute of Health Sciences, Dharan 56701, Nepal
    Ann Trop Med Parasitol 102:729-41. 2008
    ..Various combinations of these interventions (based on country-specific social and economic factors) may, however, be the best and most cost-effective choice...
  16. ncbi request reprint Adenosine deaminase activity in sera of patients with visceral leishmaniasis in Nepal
    N Baral
    Department of Biochemistry, BP Koirala Institute of Health Sciences, Ghopa, BPKIHS, Dharan, Nepal
    Trop Doct 35:86-8. 2005
    ....
  17. pmc Erythrocyte glutathione status in human visceral leishmaniasis
    D P Neupane
    Department of Biochemistry, B P Koirala Institute of Health Sciences, Dharan, Nepal
    Indian J Clin Biochem 23:95-7. 2008
    ..We concluded that visceral leishmaniasis patients are in oxidative stress which most likely induces the endogenous antioxidant such as GSH or its poor utilization by cells...
  18. ncbi request reprint Neurocycticercosis--a review
    J A Ansari
    BP Koirala Institute of Health Sciences, Dharan, Nepal
    Kathmandu Univ Med J (KUMJ) 1:48-55. 2003
  19. ncbi request reprint Chronic cough in thymoma
    K K Agrawaal
    Department of Internal Medicine, BPKIHS, Dharan, Nepal
    JNMA J Nepal Med Assoc 49:164-6. 2010
    ..After all the common causes for chronic cough have been ruled out, unusual causes should also be considered in the differential diagnosis...
  20. ncbi request reprint Pott's spine and paraplegia
    M P Gautam
    Bir Hospital, NAMS, Kathmandu, Nepal
    JNMA J Nepal Med Assoc 44:106-15. 2005
    ....
  21. ncbi request reprint Gene expression profiling of Leishmania (Leishmania) donovani: overcoming technical variation and exploiting biological variation
    S Decuypere
    Division of Infection and Immunity, Institute of Biomedical and Life Sciences, University of Glasgow, G12 8QQ, UK
    Parasitology 135:183-94. 2008
    ....
  22. ncbi request reprint Prospective evaluation and comparison of the direct agglutination test and an rK39-antigen-based dipstick test for the diagnosis of suspected kala-azar in Nepal
    F Chappuis
    Department of Community Medicine, Geneva University Hospital, Geneva, Switzerland
    Trop Med Int Health 8:277-85. 2003
    ..The rK39 dipstick is cheaper and easier to use than the DAT and could be used widely provided that both its performance and production remain stable...
  23. ncbi request reprint Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent
    M Boelaert
    Epidemiology and Disease Control Unit, Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerp, Belgium
    Trans R Soc Trop Med Hyg 102:32-40. 2008
    ..FD-DAT and rK39 can be recommended for clinical practice on the Indian subcontinent. In East Africa, their clinical use should be carefully monitored. More work is needed to improve existing formats, and to develop better VL diagnostics...